nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—ADRA1A—Citalopram—alcohol dependence	0.49	1	CbGbCtD
Apraclonidine—Syncope vasovagal—Citalopram—alcohol dependence	0.0114	0.0361	CcSEcCtD
Apraclonidine—Upset stomach—Disulfiram—alcohol dependence	0.0113	0.0358	CcSEcCtD
Apraclonidine—Blepharospasm—Citalopram—alcohol dependence	0.00929	0.0294	CcSEcCtD
Apraclonidine—Endophthalmitis—Acamprosate—alcohol dependence	0.00767	0.0243	CcSEcCtD
Apraclonidine—Presyncope—Citalopram—alcohol dependence	0.00688	0.0218	CcSEcCtD
Apraclonidine—Eye pain—Disulfiram—alcohol dependence	0.00596	0.0189	CcSEcCtD
Apraclonidine—Upset stomach—Naltrexone—alcohol dependence	0.00527	0.0167	CcSEcCtD
Apraclonidine—Eye pruritus—Citalopram—alcohol dependence	0.0049	0.0155	CcSEcCtD
Apraclonidine—Abdominal discomfort—Disulfiram—alcohol dependence	0.00446	0.0141	CcSEcCtD
Apraclonidine—Throat irritation—Citalopram—alcohol dependence	0.00434	0.0137	CcSEcCtD
Apraclonidine—Eyelid oedema—Citalopram—alcohol dependence	0.00434	0.0137	CcSEcCtD
Apraclonidine—Rhinorrhoea—Naltrexone—alcohol dependence	0.00426	0.0135	CcSEcCtD
Apraclonidine—Photophobia—Acamprosate—alcohol dependence	0.00343	0.0108	CcSEcCtD
Apraclonidine—Keratitis—Citalopram—alcohol dependence	0.00338	0.0107	CcSEcCtD
Apraclonidine—Upset stomach—Citalopram—alcohol dependence	0.00334	0.0106	CcSEcCtD
Apraclonidine—Abnormal vision—Acamprosate—alcohol dependence	0.00318	0.0101	CcSEcCtD
Apraclonidine—Libido decreased—Acamprosate—alcohol dependence	0.00286	0.00904	CcSEcCtD
Apraclonidine—Mydriasis—Citalopram—alcohol dependence	0.00274	0.00868	CcSEcCtD
Apraclonidine—Libido decreased—Naltrexone—alcohol dependence	0.0027	0.00856	CcSEcCtD
Apraclonidine—Rhinorrhoea—Citalopram—alcohol dependence	0.0027	0.00855	CcSEcCtD
Apraclonidine—Pallor—Citalopram—alcohol dependence	0.00264	0.00835	CcSEcCtD
Apraclonidine—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00263	0.00832	CcSEcCtD
Apraclonidine—Eye irritation—Citalopram—alcohol dependence	0.00256	0.00811	CcSEcCtD
Apraclonidine—Face oedema—Acamprosate—alcohol dependence	0.00256	0.0081	CcSEcCtD
Apraclonidine—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00249	0.00787	CcSEcCtD
Apraclonidine—Face oedema—Naltrexone—alcohol dependence	0.00242	0.00766	CcSEcCtD
Apraclonidine—Irritability—Naltrexone—alcohol dependence	0.00239	0.00757	CcSEcCtD
Apraclonidine—Paraesthesia—Disulfiram—alcohol dependence	0.00237	0.00751	CcSEcCtD
Apraclonidine—Somnolence—Disulfiram—alcohol dependence	0.00235	0.00744	CcSEcCtD
Apraclonidine—Asthma—Acamprosate—alcohol dependence	0.00229	0.00725	CcSEcCtD
Apraclonidine—Fatigue—Disulfiram—alcohol dependence	0.00228	0.00721	CcSEcCtD
Apraclonidine—Pain—Disulfiram—alcohol dependence	0.00226	0.00715	CcSEcCtD
Apraclonidine—Nasopharyngitis—Naltrexone—alcohol dependence	0.00224	0.00709	CcSEcCtD
Apraclonidine—Coordination abnormal—Citalopram—alcohol dependence	0.00223	0.00705	CcSEcCtD
Apraclonidine—Dermatitis contact—Citalopram—alcohol dependence	0.00216	0.00684	CcSEcCtD
Apraclonidine—Abdominal discomfort—Naltrexone—alcohol dependence	0.00208	0.00657	CcSEcCtD
Apraclonidine—Photophobia—Citalopram—alcohol dependence	0.00206	0.0065	CcSEcCtD
Apraclonidine—Dry eye—Citalopram—alcohol dependence	0.00202	0.0064	CcSEcCtD
Apraclonidine—Infestation—Naltrexone—alcohol dependence	0.00193	0.00611	CcSEcCtD
Apraclonidine—Infestation NOS—Naltrexone—alcohol dependence	0.00193	0.00611	CcSEcCtD
Apraclonidine—Abnormal vision—Citalopram—alcohol dependence	0.00191	0.00604	CcSEcCtD
Apraclonidine—Asthenia—Disulfiram—alcohol dependence	0.0019	0.006	CcSEcCtD
Apraclonidine—Conjunctivitis—Naltrexone—alcohol dependence	0.00188	0.00594	CcSEcCtD
Apraclonidine—Rhinitis—Acamprosate—alcohol dependence	0.00184	0.00582	CcSEcCtD
Apraclonidine—Haemorrhage—Acamprosate—alcohol dependence	0.00183	0.0058	CcSEcCtD
Apraclonidine—Pharyngitis—Acamprosate—alcohol dependence	0.00182	0.00576	CcSEcCtD
Apraclonidine—Oedema peripheral—Acamprosate—alcohol dependence	0.00181	0.00571	CcSEcCtD
Apraclonidine—Visual impairment—Acamprosate—alcohol dependence	0.00177	0.00559	CcSEcCtD
Apraclonidine—Eye pain—Citalopram—alcohol dependence	0.00176	0.00557	CcSEcCtD
Apraclonidine—Dizziness—Disulfiram—alcohol dependence	0.00175	0.00553	CcSEcCtD
Apraclonidine—Pharyngitis—Naltrexone—alcohol dependence	0.00172	0.00545	CcSEcCtD
Apraclonidine—Libido decreased—Citalopram—alcohol dependence	0.00171	0.00542	CcSEcCtD
Apraclonidine—Headache—Disulfiram—alcohol dependence	0.00166	0.00524	CcSEcCtD
Apraclonidine—Eye disorder—Naltrexone—alcohol dependence	0.00162	0.00513	CcSEcCtD
Apraclonidine—Mental disorder—Acamprosate—alcohol dependence	0.00161	0.00508	CcSEcCtD
Apraclonidine—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00158	0.00499	CcSEcCtD
Apraclonidine—Angiopathy—Naltrexone—alcohol dependence	0.00157	0.00498	CcSEcCtD
Apraclonidine—Tension—Acamprosate—alcohol dependence	0.00157	0.00496	CcSEcCtD
Apraclonidine—Mediastinal disorder—Naltrexone—alcohol dependence	0.00156	0.00495	CcSEcCtD
Apraclonidine—Dysgeusia—Acamprosate—alcohol dependence	0.00156	0.00495	CcSEcCtD
Apraclonidine—Nervousness—Acamprosate—alcohol dependence	0.00155	0.0049	CcSEcCtD
Apraclonidine—Face oedema—Citalopram—alcohol dependence	0.00153	0.00485	CcSEcCtD
Apraclonidine—Mental disorder—Naltrexone—alcohol dependence	0.00152	0.00481	CcSEcCtD
Apraclonidine—Irritability—Citalopram—alcohol dependence	0.00152	0.0048	CcSEcCtD
Apraclonidine—Tension—Naltrexone—alcohol dependence	0.00148	0.00469	CcSEcCtD
Apraclonidine—Ill-defined disorder—Acamprosate—alcohol dependence	0.00148	0.00469	CcSEcCtD
Apraclonidine—Dysgeusia—Naltrexone—alcohol dependence	0.00148	0.00468	CcSEcCtD
Apraclonidine—Nervousness—Naltrexone—alcohol dependence	0.00147	0.00464	CcSEcCtD
Apraclonidine—Malaise—Acamprosate—alcohol dependence	0.00144	0.00455	CcSEcCtD
Apraclonidine—Syncope—Acamprosate—alcohol dependence	0.00143	0.00453	CcSEcCtD
Apraclonidine—Vision blurred—Naltrexone—alcohol dependence	0.00142	0.0045	CcSEcCtD
Apraclonidine—Nasopharyngitis—Citalopram—alcohol dependence	0.00142	0.0045	CcSEcCtD
Apraclonidine—Palpitations—Acamprosate—alcohol dependence	0.00141	0.00446	CcSEcCtD
Apraclonidine—Ill-defined disorder—Naltrexone—alcohol dependence	0.0014	0.00443	CcSEcCtD
Apraclonidine—Asthma—Citalopram—alcohol dependence	0.00137	0.00434	CcSEcCtD
Apraclonidine—Malaise—Naltrexone—alcohol dependence	0.00136	0.00431	CcSEcCtD
Apraclonidine—Myalgia—Acamprosate—alcohol dependence	0.00136	0.0043	CcSEcCtD
Apraclonidine—Chest pain—Acamprosate—alcohol dependence	0.00136	0.0043	CcSEcCtD
Apraclonidine—Syncope—Naltrexone—alcohol dependence	0.00135	0.00428	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00135	0.00427	CcSEcCtD
Apraclonidine—Discomfort—Acamprosate—alcohol dependence	0.00134	0.00425	CcSEcCtD
Apraclonidine—Palpitations—Naltrexone—alcohol dependence	0.00133	0.00422	CcSEcCtD
Apraclonidine—Dry mouth—Acamprosate—alcohol dependence	0.00133	0.0042	CcSEcCtD
Apraclonidine—Abdominal discomfort—Citalopram—alcohol dependence	0.00132	0.00417	CcSEcCtD
Apraclonidine—Infection—Acamprosate—alcohol dependence	0.00129	0.00409	CcSEcCtD
Apraclonidine—Myalgia—Naltrexone—alcohol dependence	0.00129	0.00407	CcSEcCtD
Apraclonidine—Chest pain—Naltrexone—alcohol dependence	0.00129	0.00407	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00128	0.00404	CcSEcCtD
Apraclonidine—Discomfort—Naltrexone—alcohol dependence	0.00127	0.00402	CcSEcCtD
Apraclonidine—Skin disorder—Acamprosate—alcohol dependence	0.00127	0.004	CcSEcCtD
Apraclonidine—Dry mouth—Naltrexone—alcohol dependence	0.00126	0.00398	CcSEcCtD
Apraclonidine—Oedema—Naltrexone—alcohol dependence	0.00123	0.0039	CcSEcCtD
Apraclonidine—Infection—Naltrexone—alcohol dependence	0.00122	0.00387	CcSEcCtD
Apraclonidine—Infestation NOS—Citalopram—alcohol dependence	0.00122	0.00387	CcSEcCtD
Apraclonidine—Infestation—Citalopram—alcohol dependence	0.00122	0.00387	CcSEcCtD
Apraclonidine—Nervous system disorder—Naltrexone—alcohol dependence	0.00121	0.00382	CcSEcCtD
Apraclonidine—Skin disorder—Naltrexone—alcohol dependence	0.0012	0.00379	CcSEcCtD
Apraclonidine—Conjunctivitis—Citalopram—alcohol dependence	0.00119	0.00377	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00119	0.00375	CcSEcCtD
Apraclonidine—Insomnia—Acamprosate—alcohol dependence	0.00118	0.00373	CcSEcCtD
Apraclonidine—Paraesthesia—Acamprosate—alcohol dependence	0.00117	0.0037	CcSEcCtD
Apraclonidine—Dyspnoea—Acamprosate—alcohol dependence	0.00116	0.00367	CcSEcCtD
Apraclonidine—Somnolence—Acamprosate—alcohol dependence	0.00116	0.00366	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00112	0.00356	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00112	0.00355	CcSEcCtD
Apraclonidine—Bradycardia—Citalopram—alcohol dependence	0.00112	0.00354	CcSEcCtD
Apraclonidine—Insomnia—Naltrexone—alcohol dependence	0.00111	0.00353	CcSEcCtD
Apraclonidine—Pain—Acamprosate—alcohol dependence	0.00111	0.00352	CcSEcCtD
Apraclonidine—Constipation—Acamprosate—alcohol dependence	0.00111	0.00352	CcSEcCtD
Apraclonidine—Paraesthesia—Naltrexone—alcohol dependence	0.00111	0.0035	CcSEcCtD
Apraclonidine—Rhinitis—Citalopram—alcohol dependence	0.0011	0.00349	CcSEcCtD
Apraclonidine—Haemorrhage—Citalopram—alcohol dependence	0.0011	0.00348	CcSEcCtD
Apraclonidine—Dyspnoea—Naltrexone—alcohol dependence	0.0011	0.00348	CcSEcCtD
Apraclonidine—Somnolence—Naltrexone—alcohol dependence	0.0011	0.00347	CcSEcCtD
Apraclonidine—Pharyngitis—Citalopram—alcohol dependence	0.00109	0.00345	CcSEcCtD
Apraclonidine—Oedema peripheral—Citalopram—alcohol dependence	0.00108	0.00343	CcSEcCtD
Apraclonidine—Feeling abnormal—Acamprosate—alcohol dependence	0.00107	0.0034	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00107	0.00337	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00106	0.00337	CcSEcCtD
Apraclonidine—Fatigue—Naltrexone—alcohol dependence	0.00106	0.00336	CcSEcCtD
Apraclonidine—Visual impairment—Citalopram—alcohol dependence	0.00106	0.00335	CcSEcCtD
Apraclonidine—Pain—Naltrexone—alcohol dependence	0.00105	0.00333	CcSEcCtD
Apraclonidine—Constipation—Naltrexone—alcohol dependence	0.00105	0.00333	CcSEcCtD
Apraclonidine—Abdominal pain—Acamprosate—alcohol dependence	0.00103	0.00326	CcSEcCtD
Apraclonidine—Eye disorder—Citalopram—alcohol dependence	0.00103	0.00325	CcSEcCtD
Apraclonidine—Feeling abnormal—Naltrexone—alcohol dependence	0.00102	0.00321	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00101	0.00319	CcSEcCtD
Apraclonidine—Angiopathy—Citalopram—alcohol dependence	0.000997	0.00316	CcSEcCtD
Apraclonidine—Mediastinal disorder—Citalopram—alcohol dependence	0.000991	0.00313	CcSEcCtD
Apraclonidine—Arrhythmia—Citalopram—alcohol dependence	0.000982	0.00311	CcSEcCtD
Apraclonidine—Abdominal pain—Naltrexone—alcohol dependence	0.000974	0.00308	CcSEcCtD
Apraclonidine—Mental disorder—Citalopram—alcohol dependence	0.000963	0.00305	CcSEcCtD
Apraclonidine—Hypersensitivity—Acamprosate—alcohol dependence	0.00096	0.00304	CcSEcCtD
Apraclonidine—Erythema—Citalopram—alcohol dependence	0.000957	0.00303	CcSEcCtD
Apraclonidine—Tension—Citalopram—alcohol dependence	0.000939	0.00297	CcSEcCtD
Apraclonidine—Dysgeusia—Citalopram—alcohol dependence	0.000937	0.00296	CcSEcCtD
Apraclonidine—Asthenia—Acamprosate—alcohol dependence	0.000935	0.00296	CcSEcCtD
Apraclonidine—Nervousness—Citalopram—alcohol dependence	0.000929	0.00294	CcSEcCtD
Apraclonidine—Pruritus—Acamprosate—alcohol dependence	0.000922	0.00292	CcSEcCtD
Apraclonidine—Hypersensitivity—Naltrexone—alcohol dependence	0.000908	0.00287	CcSEcCtD
Apraclonidine—Vision blurred—Citalopram—alcohol dependence	0.000902	0.00285	CcSEcCtD
Apraclonidine—Diarrhoea—Acamprosate—alcohol dependence	0.000891	0.00282	CcSEcCtD
Apraclonidine—Ill-defined disorder—Citalopram—alcohol dependence	0.000888	0.00281	CcSEcCtD
Apraclonidine—Asthenia—Naltrexone—alcohol dependence	0.000884	0.0028	CcSEcCtD
Apraclonidine—Pruritus—Naltrexone—alcohol dependence	0.000872	0.00276	CcSEcCtD
Apraclonidine—Malaise—Citalopram—alcohol dependence	0.000863	0.00273	CcSEcCtD
Apraclonidine—Dizziness—Acamprosate—alcohol dependence	0.000862	0.00273	CcSEcCtD
Apraclonidine—Syncope—Citalopram—alcohol dependence	0.000858	0.00271	CcSEcCtD
Apraclonidine—Palpitations—Citalopram—alcohol dependence	0.000846	0.00268	CcSEcCtD
Apraclonidine—Diarrhoea—Naltrexone—alcohol dependence	0.000843	0.00267	CcSEcCtD
Apraclonidine—Vomiting—Acamprosate—alcohol dependence	0.000828	0.00262	CcSEcCtD
Apraclonidine—Dermatitis—Acamprosate—alcohol dependence	0.000821	0.0026	CcSEcCtD
Apraclonidine—Headache—Acamprosate—alcohol dependence	0.000816	0.00258	CcSEcCtD
Apraclonidine—Dizziness—Naltrexone—alcohol dependence	0.000815	0.00258	CcSEcCtD
Apraclonidine—Myalgia—Citalopram—alcohol dependence	0.000815	0.00258	CcSEcCtD
Apraclonidine—Chest pain—Citalopram—alcohol dependence	0.000815	0.00258	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000809	0.00256	CcSEcCtD
Apraclonidine—Discomfort—Citalopram—alcohol dependence	0.000805	0.00255	CcSEcCtD
Apraclonidine—Dry mouth—Citalopram—alcohol dependence	0.000797	0.00252	CcSEcCtD
Apraclonidine—Vomiting—Naltrexone—alcohol dependence	0.000784	0.00248	CcSEcCtD
Apraclonidine—Oedema—Citalopram—alcohol dependence	0.000781	0.00247	CcSEcCtD
Apraclonidine—Dermatitis—Naltrexone—alcohol dependence	0.000777	0.00246	CcSEcCtD
Apraclonidine—Infection—Citalopram—alcohol dependence	0.000776	0.00245	CcSEcCtD
Apraclonidine—Nausea—Acamprosate—alcohol dependence	0.000774	0.00245	CcSEcCtD
Apraclonidine—Headache—Naltrexone—alcohol dependence	0.000772	0.00244	CcSEcCtD
Apraclonidine—Nervous system disorder—Citalopram—alcohol dependence	0.000766	0.00242	CcSEcCtD
Apraclonidine—Skin disorder—Citalopram—alcohol dependence	0.000759	0.0024	CcSEcCtD
Apraclonidine—Nausea—Naltrexone—alcohol dependence	0.000732	0.00232	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000712	0.00225	CcSEcCtD
Apraclonidine—Insomnia—Citalopram—alcohol dependence	0.000706	0.00223	CcSEcCtD
Apraclonidine—Paraesthesia—Citalopram—alcohol dependence	0.000701	0.00222	CcSEcCtD
Apraclonidine—Dyspnoea—Citalopram—alcohol dependence	0.000696	0.0022	CcSEcCtD
Apraclonidine—Somnolence—Citalopram—alcohol dependence	0.000694	0.0022	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000674	0.00213	CcSEcCtD
Apraclonidine—Fatigue—Citalopram—alcohol dependence	0.000673	0.00213	CcSEcCtD
Apraclonidine—Pain—Citalopram—alcohol dependence	0.000668	0.00211	CcSEcCtD
Apraclonidine—Constipation—Citalopram—alcohol dependence	0.000668	0.00211	CcSEcCtD
Apraclonidine—Feeling abnormal—Citalopram—alcohol dependence	0.000644	0.00204	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000639	0.00202	CcSEcCtD
Apraclonidine—Abdominal pain—Citalopram—alcohol dependence	0.000617	0.00195	CcSEcCtD
Apraclonidine—ADRA1A—brainstem—alcohol dependence	0.000578	0.058	CbGeAlD
Apraclonidine—Hypersensitivity—Citalopram—alcohol dependence	0.000575	0.00182	CcSEcCtD
Apraclonidine—Asthenia—Citalopram—alcohol dependence	0.00056	0.00177	CcSEcCtD
Apraclonidine—ADRA1A—forebrain—alcohol dependence	0.000558	0.056	CbGeAlD
Apraclonidine—Pruritus—Citalopram—alcohol dependence	0.000553	0.00175	CcSEcCtD
Apraclonidine—Diarrhoea—Citalopram—alcohol dependence	0.000534	0.00169	CcSEcCtD
Apraclonidine—Dizziness—Citalopram—alcohol dependence	0.000516	0.00163	CcSEcCtD
Apraclonidine—Vomiting—Citalopram—alcohol dependence	0.000497	0.00157	CcSEcCtD
Apraclonidine—ADRA2C—adrenal cortex—alcohol dependence	0.000493	0.0494	CbGeAlD
Apraclonidine—Dermatitis—Citalopram—alcohol dependence	0.000492	0.00156	CcSEcCtD
Apraclonidine—Headache—Citalopram—alcohol dependence	0.000489	0.00155	CcSEcCtD
Apraclonidine—ADRA1A—cardiovascular system—alcohol dependence	0.000472	0.0473	CbGeAlD
Apraclonidine—Nausea—Citalopram—alcohol dependence	0.000464	0.00147	CcSEcCtD
Apraclonidine—ADRA2C—pancreas—alcohol dependence	0.000437	0.0439	CbGeAlD
Apraclonidine—ADRA2A—forebrain—alcohol dependence	0.000424	0.0426	CbGeAlD
Apraclonidine—ADRA1A—blood—alcohol dependence	0.000373	0.0374	CbGeAlD
Apraclonidine—ADRA2C—blood—alcohol dependence	0.000356	0.0357	CbGeAlD
Apraclonidine—ADRA2C—midbrain—alcohol dependence	0.000351	0.0352	CbGeAlD
Apraclonidine—ADRA2A—pancreas—alcohol dependence	0.000349	0.035	CbGeAlD
Apraclonidine—ADRA2A—gonad—alcohol dependence	0.000326	0.0327	CbGeAlD
Apraclonidine—ADRA1A—endocrine gland—alcohol dependence	0.000324	0.0325	CbGeAlD
Apraclonidine—ADRA1A—nervous system—alcohol dependence	0.000303	0.0304	CbGeAlD
Apraclonidine—ADRA2C—testis—alcohol dependence	0.000294	0.0295	CbGeAlD
Apraclonidine—ADRA1A—liver—alcohol dependence	0.000292	0.0293	CbGeAlD
Apraclonidine—ADRA1A—central nervous system—alcohol dependence	0.000292	0.0293	CbGeAlD
Apraclonidine—ADRA2C—nervous system—alcohol dependence	0.000289	0.029	CbGeAlD
Apraclonidine—ADRA1A—cerebellum—alcohol dependence	0.000285	0.0286	CbGeAlD
Apraclonidine—ADRA2A—blood—alcohol dependence	0.000284	0.0285	CbGeAlD
Apraclonidine—ADRA2A—midbrain—alcohol dependence	0.00028	0.0281	CbGeAlD
Apraclonidine—ADRA2C—liver—alcohol dependence	0.000278	0.0279	CbGeAlD
Apraclonidine—ADRA2C—central nervous system—alcohol dependence	0.000278	0.0279	CbGeAlD
Apraclonidine—ADRA2C—cerebellum—alcohol dependence	0.000272	0.0273	CbGeAlD
Apraclonidine—ADRA2A—endocrine gland—alcohol dependence	0.000246	0.0247	CbGeAlD
Apraclonidine—ADRA2A—testis—alcohol dependence	0.000235	0.0235	CbGeAlD
Apraclonidine—ADRA1A—brain—alcohol dependence	0.000232	0.0232	CbGeAlD
Apraclonidine—ADRA2A—nervous system—alcohol dependence	0.00023	0.0231	CbGeAlD
Apraclonidine—ADRA2A—central nervous system—alcohol dependence	0.000222	0.0223	CbGeAlD
Apraclonidine—ADRA2C—brain—alcohol dependence	0.000221	0.0221	CbGeAlD
Apraclonidine—ADRA2A—cerebellum—alcohol dependence	0.000217	0.0217	CbGeAlD
Apraclonidine—ADRA1A—GPCR ligand binding—DRD4—alcohol dependence	0.000212	0.00115	CbGpPWpGaD
Apraclonidine—ADRA2C—G alpha (i) signalling events—POMC—alcohol dependence	0.000209	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—OPRD1—alcohol dependence	0.000208	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000208	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CHRM2—alcohol dependence	0.000206	0.00112	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CRHR1—alcohol dependence	0.000204	0.00111	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ADH4—alcohol dependence	0.000204	0.0011	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—AVP—alcohol dependence	0.000203	0.0011	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000203	0.0011	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CNR1—alcohol dependence	0.000202	0.0011	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—OPRD1—alcohol dependence	0.0002	0.00109	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—PDYN—alcohol dependence	0.0002	0.00108	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CRHR1—alcohol dependence	0.000199	0.00108	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR7—alcohol dependence	0.000197	0.00107	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—DRD2—alcohol dependence	0.000197	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000197	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—DRD4—alcohol dependence	0.000197	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—OPRK1—alcohol dependence	0.000196	0.00106	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADH1A—alcohol dependence	0.000194	0.00105	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—PDYN—alcohol dependence	0.000192	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CHRM2—alcohol dependence	0.000192	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—AVP—alcohol dependence	0.00019	0.00103	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—OPRM1—alcohol dependence	0.000189	0.00102	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CNR1—alcohol dependence	0.000188	0.00102	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CHRM2—alcohol dependence	0.000187	0.00101	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—OPRD1—alcohol dependence	0.000186	0.00101	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CRHR1—alcohol dependence	0.000186	0.00101	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—DRD2—alcohol dependence	0.000183	0.000994	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR7—alcohol dependence	0.000183	0.000994	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—OPRK1—alcohol dependence	0.000183	0.000993	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—OPRD1—alcohol dependence	0.000182	0.000987	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000182	0.000984	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CRHR1—alcohol dependence	0.000179	0.000969	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—PDYN—alcohol dependence	0.000179	0.000968	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000178	0.000963	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—OPRM1—alcohol dependence	0.000176	0.000957	CbGpPWpGaD
Apraclonidine—ADRA2A—brain—alcohol dependence	0.000176	0.0177	CbGeAlD
Apraclonidine—ADRA1A—Signaling by GPCR—PDYN—alcohol dependence	0.000175	0.000947	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CHRM2—alcohol dependence	0.000175	0.000946	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—NPY—alcohol dependence	0.000174	0.000943	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ADH7—alcohol dependence	0.000173	0.000938	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—OPRM1—alcohol dependence	0.000172	0.00093	CbGpPWpGaD
Apraclonidine—ADRA2A—G alpha (i) signalling events—POMC—alcohol dependence	0.000169	0.000919	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—HTR2A—alcohol dependence	0.000169	0.000918	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—OPRD1—alcohol dependence	0.000169	0.000917	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000169	0.000915	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CHRM2—alcohol dependence	0.000168	0.000911	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CRH—alcohol dependence	0.000168	0.00091	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR1B—alcohol dependence	0.000168	0.00091	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—AVP—alcohol dependence	0.000166	0.000901	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CRHR1—alcohol dependence	0.000166	0.0009	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GGT2—alcohol dependence	0.000166	0.0009	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000166	0.000899	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADH4—alcohol dependence	0.000165	0.000896	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—NPY—alcohol dependence	0.000162	0.000881	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CRHR1—alcohol dependence	0.000162	0.00088	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PDYN—alcohol dependence	0.000162	0.000879	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—OPRM1—alcohol dependence	0.00016	0.000869	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—OPRK1—alcohol dependence	0.00016	0.000868	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR2A—alcohol dependence	0.000158	0.000857	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—NPY—alcohol dependence	0.000158	0.000856	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR1B—alcohol dependence	0.000157	0.00085	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CRH—alcohol dependence	0.000157	0.00085	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CHRM2—alcohol dependence	0.000156	0.000847	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—AVP—alcohol dependence	0.000154	0.000837	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—OPRM1—alcohol dependence	0.000154	0.000836	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CHRM2—alcohol dependence	0.000153	0.000827	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR1B—alcohol dependence	0.000152	0.000826	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CRH—alcohol dependence	0.000152	0.000826	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ADH1B—alcohol dependence	0.000152	0.000823	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CRHR1—alcohol dependence	0.000151	0.000818	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—OPRK1—alcohol dependence	0.000149	0.000806	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—NPY—alcohol dependence	0.000147	0.0008	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—DRD4—alcohol dependence	0.000147	0.000795	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000145	0.000786	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—OPRM1—alcohol dependence	0.000143	0.000777	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CRH—alcohol dependence	0.000142	0.000772	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR1B—alcohol dependence	0.000142	0.000772	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—NPY—alcohol dependence	0.000142	0.00077	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CHRM2—alcohol dependence	0.000142	0.000769	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADH7—alcohol dependence	0.000141	0.000762	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—OPRM1—alcohol dependence	0.00014	0.00076	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CNR1—alcohol dependence	0.00014	0.000759	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR2A—alcohol dependence	0.000138	0.00075	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR1B—alcohol dependence	0.000137	0.000743	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CRH—alcohol dependence	0.000137	0.000743	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—DRD4—alcohol dependence	0.000137	0.000743	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR7—alcohol dependence	0.000137	0.000741	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—DRD2—alcohol dependence	0.000137	0.000741	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—POMC—alcohol dependence	0.000135	0.000733	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GGT2—alcohol dependence	0.000135	0.000731	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000135	0.00073	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—DRD4—alcohol dependence	0.000133	0.000722	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—NPY—alcohol dependence	0.000132	0.000715	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—OPRD1—alcohol dependence	0.000132	0.000714	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CNR1—alcohol dependence	0.000131	0.000709	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—OPRM1—alcohol dependence	0.00013	0.000706	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—NPY—alcohol dependence	0.000129	0.000699	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR2A—alcohol dependence	0.000128	0.000696	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR7—alcohol dependence	0.000128	0.000692	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—DRD2—alcohol dependence	0.000128	0.000692	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CRH—alcohol dependence	0.000127	0.00069	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR1B—alcohol dependence	0.000127	0.00069	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CNR1—alcohol dependence	0.000127	0.000689	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PDYN—alcohol dependence	0.000126	0.000685	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—POMC—alcohol dependence	0.000126	0.000685	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MAOB—alcohol dependence	0.000126	0.000682	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR1B—alcohol dependence	0.000124	0.000674	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CRH—alcohol dependence	0.000124	0.000674	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—DRD4—alcohol dependence	0.000124	0.000674	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—DRD2—alcohol dependence	0.000124	0.000673	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR7—alcohol dependence	0.000124	0.000673	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADH1B—alcohol dependence	0.000123	0.000668	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—OPRD1—alcohol dependence	0.000123	0.000667	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—NPY—alcohol dependence	0.00012	0.00065	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—DRD4—alcohol dependence	0.00012	0.000649	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CNR1—alcohol dependence	0.000119	0.000644	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PDYN—alcohol dependence	0.000118	0.00064	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—WASF2—alcohol dependence	0.000117	0.000637	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CRHR1—alcohol dependence	0.000117	0.000637	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—DRD2—alcohol dependence	0.000116	0.000628	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR7—alcohol dependence	0.000116	0.000628	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CRH—alcohol dependence	0.000116	0.000627	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR1B—alcohol dependence	0.000116	0.000627	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—AVP—alcohol dependence	0.000115	0.000623	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CNR1—alcohol dependence	0.000114	0.00062	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—WASF1—alcohol dependence	0.000113	0.00061	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—DRD2—alcohol dependence	0.000112	0.000605	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR7—alcohol dependence	0.000112	0.000605	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—DRD4—alcohol dependence	0.000111	0.000603	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—POMC—alcohol dependence	0.00011	0.000599	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CHRM2—alcohol dependence	0.00011	0.000599	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CRHR1—alcohol dependence	0.00011	0.000595	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—WASF2—alcohol dependence	0.00011	0.000595	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—DRD4—alcohol dependence	0.000109	0.00059	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—OPRD1—alcohol dependence	0.000108	0.000583	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—AVP—alcohol dependence	0.000107	0.000582	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ALDH2—alcohol dependence	0.000107	0.00058	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CNR1—alcohol dependence	0.000106	0.000576	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—WASF1—alcohol dependence	0.000105	0.00057	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—AVP—alcohol dependence	0.000104	0.000566	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CNR1—alcohol dependence	0.000104	0.000563	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—DRD2—alcohol dependence	0.000104	0.000562	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR7—alcohol dependence	0.000104	0.000562	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PDYN—alcohol dependence	0.000103	0.000559	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CHRM2—alcohol dependence	0.000103	0.000559	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—POMC—alcohol dependence	0.000103	0.000556	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MAOB—alcohol dependence	0.000102	0.000554	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—OPRM1—alcohol dependence	0.000101	0.00055	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR7—alcohol dependence	0.000101	0.000549	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—DRD2—alcohol dependence	0.000101	0.000549	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—DRD4—alcohol dependence	0.000101	0.000548	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—OPRD1—alcohol dependence	9.99e-05	0.000542	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—AVP—alcohol dependence	9.75e-05	0.000529	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CNR1—alcohol dependence	9.64e-05	0.000523	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—WASF2—alcohol dependence	9.59e-05	0.00052	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CRHR1—alcohol dependence	9.59e-05	0.00052	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PDYN—alcohol dependence	9.58e-05	0.00052	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR2A—alcohol dependence	9.57e-05	0.000519	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—OPRM1—alcohol dependence	9.47e-05	0.000513	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—DRD2—alcohol dependence	9.41e-05	0.00051	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR7—alcohol dependence	9.41e-05	0.00051	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—AVP—alcohol dependence	9.39e-05	0.000509	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NPY—alcohol dependence	9.33e-05	0.000506	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—WASF1—alcohol dependence	9.19e-05	0.000498	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GOT2—alcohol dependence	9.09e-05	0.000493	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CHRM2—alcohol dependence	9.01e-05	0.000489	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR1B—alcohol dependence	9e-05	0.000488	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CRH—alcohol dependence	9e-05	0.000488	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR2A—alcohol dependence	8.93e-05	0.000485	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—WASF2—alcohol dependence	8.91e-05	0.000483	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CRHR1—alcohol dependence	8.91e-05	0.000483	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—AVP—alcohol dependence	8.72e-05	0.000473	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NPY—alcohol dependence	8.71e-05	0.000472	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR2A—alcohol dependence	8.69e-05	0.000471	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ALDH2—alcohol dependence	8.68e-05	0.000471	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CYP2E1—alcohol dependence	8.55e-05	0.000463	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—WASF1—alcohol dependence	8.54e-05	0.000463	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—AVP—alcohol dependence	8.52e-05	0.000462	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR1B—alcohol dependence	8.4e-05	0.000456	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CRH—alcohol dependence	8.4e-05	0.000456	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CHRM2—alcohol dependence	8.37e-05	0.000454	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—OPRM1—alcohol dependence	8.27e-05	0.000449	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR2A—alcohol dependence	8.11e-05	0.00044	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—EP300—alcohol dependence	8.02e-05	0.000435	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—AVP—alcohol dependence	7.92e-05	0.00043	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—DRD4—alcohol dependence	7.86e-05	0.000426	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GOT1—alcohol dependence	7.85e-05	0.000426	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GGT1—alcohol dependence	7.85e-05	0.000426	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR2A—alcohol dependence	7.81e-05	0.000424	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—OPRM1—alcohol dependence	7.69e-05	0.000417	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—POMC—alcohol dependence	7.64e-05	0.000414	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NPY—alcohol dependence	7.62e-05	0.000413	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CNR1—alcohol dependence	7.51e-05	0.000407	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—EP300—alcohol dependence	7.49e-05	0.000406	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GOT2—alcohol dependence	7.38e-05	0.0004	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR1B—alcohol dependence	7.35e-05	0.000398	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CRH—alcohol dependence	7.35e-05	0.000398	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—DRD4—alcohol dependence	7.35e-05	0.000398	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR7—alcohol dependence	7.33e-05	0.000397	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—DRD2—alcohol dependence	7.33e-05	0.000397	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR2A—alcohol dependence	7.26e-05	0.000394	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—POMC—alcohol dependence	7.14e-05	0.000387	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR2A—alcohol dependence	7.09e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NPY—alcohol dependence	7.08e-05	0.000384	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MAOA—alcohol dependence	7.03e-05	0.000381	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CNR1—alcohol dependence	7.01e-05	0.00038	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CYP2E1—alcohol dependence	6.94e-05	0.000376	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—POMC—alcohol dependence	6.94e-05	0.000376	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR7—alcohol dependence	6.84e-05	0.000371	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—DRD2—alcohol dependence	6.84e-05	0.000371	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR1B—alcohol dependence	6.83e-05	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CRH—alcohol dependence	6.83e-05	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR2A—alcohol dependence	6.59e-05	0.000357	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—POMC—alcohol dependence	6.48e-05	0.000351	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—DRD4—alcohol dependence	6.42e-05	0.000348	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GOT1—alcohol dependence	6.37e-05	0.000346	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GGT1—alcohol dependence	6.37e-05	0.000346	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—POMC—alcohol dependence	6.24e-05	0.000338	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—AVP—alcohol dependence	6.17e-05	0.000334	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CNR1—alcohol dependence	6.13e-05	0.000333	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—EP300—alcohol dependence	6.08e-05	0.00033	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR7—alcohol dependence	5.98e-05	0.000324	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—DRD2—alcohol dependence	5.98e-05	0.000324	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—DRD4—alcohol dependence	5.97e-05	0.000324	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—POMC—alcohol dependence	5.8e-05	0.000314	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—AVP—alcohol dependence	5.76e-05	0.000312	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MAOA—alcohol dependence	5.71e-05	0.00031	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CNR1—alcohol dependence	5.7e-05	0.000309	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—POMC—alcohol dependence	5.66e-05	0.000307	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—DRD2—alcohol dependence	5.56e-05	0.000301	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR7—alcohol dependence	5.56e-05	0.000301	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—POMC—alcohol dependence	5.26e-05	0.000285	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR2A—alcohol dependence	5.13e-05	0.000278	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—AVP—alcohol dependence	5.04e-05	0.000273	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR2A—alcohol dependence	4.79e-05	0.00026	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AVP—alcohol dependence	4.68e-05	0.000254	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—POMC—alcohol dependence	4.58e-05	0.000248	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR2A—alcohol dependence	4.19e-05	0.000227	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—POMC—alcohol dependence	4.1e-05	0.000222	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR2A—alcohol dependence	3.89e-05	0.000211	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—POMC—alcohol dependence	3.83e-05	0.000208	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—POMC—alcohol dependence	3.72e-05	0.000202	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—POMC—alcohol dependence	3.35e-05	0.000181	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—POMC—alcohol dependence	3.11e-05	0.000169	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—EP300—alcohol dependence	3.04e-05	0.000165	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EP300—alcohol dependence	2.72e-05	0.000147	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EP300—alcohol dependence	2.54e-05	0.000138	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—EP300—alcohol dependence	2.47e-05	0.000134	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EP300—alcohol dependence	2.22e-05	0.00012	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EP300—alcohol dependence	2.06e-05	0.000112	CbGpPWpGaD
